Recombinant antibody production leverages mammalian cell lines for the generation of therapeutic antibodies. Chinese hamster ovary (CHO) cells emerged as a leading platform due to their capability more info in producing complex, humanized antibodies. High-yield production of CHO cells is crucial for commercial success and involves meticulous optimi